Table of Contents
ISRN Pediatrics
Volume 2012, Article ID 859873, 4 pages
http://dx.doi.org/10.5402/2012/859873
Clinical Study

Diagnostic Value of Exhaled Carbon Monoxide as an Early Marker of Exacerbation in Children with Chronic Lung Diseases

Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo 11321, Egypt

Received 14 July 2012; Accepted 9 August 2012

Academic Editors: T. V. Brogan and J. A. O'Neill

Copyright © 2012 Karima A. Abd EL Khalek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Horváth and R. Gajdócsy, “Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance,” Journal of Breath Research, vol. 4, no. 4, Article ID 047102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Zhao, P. D. Schloss, L. M. Kalikin et al., “Decade-long bacterial community dynamics in cystic fibrosis airways,” Proceedings of the National Academy of Sciences, vol. 109, no. 15, pp. 5809–5814, 2012. View at Google Scholar
  3. C. H. Goss and J. L. Burns, “Exacerbations in cystic fibrosis·1: epidemiology and pathogenesis,” Thorax, vol. 62, no. 4, pp. 360–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. W. B. M. Gerritsen, J. Asin, P. Zanen, J. M. M. van den Bosch, and F. J. L. M. Haas, “Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients,” Respiratory Medicine, vol. 99, no. 1, pp. 84–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Hoffman, J. Choi, G. W. Rodway, and J. M. Sethi, “Markers of lung disease in exhaled breath: nitric oxide,” Biological Research for Nursing, vol. 7, no. 4, pp. 241–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Babusikova, M. Jesenak, P. Durdik, D. Dobrota, and P. Banovcin, “Exhaled carbon monoxide as a new marker of respiratory diseases in children,” Journal of Physiology and Pharmacology, vol. 59, no. 6, pp. 9–17, 2008. View at Google Scholar · View at Scopus
  7. H. Grasemann, I. Ioannidis, R. P. Tomkiewicz, H. De Groot, B. K. Rubin, and F. Ratjen, “Nitric oxide metabolites in cystic fibrosis lung disease,” Archives of Disease in Childhood, vol. 78, no. 1, pp. 49–53, 1998. View at Google Scholar · View at Scopus
  8. J. Kanga, R. Kuhn, L. Craigmyle, D. Haverstock, and D. Church, “Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation,” Clinical Therapeutics, vol. 21, no. 8, pp. 1343–1356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. G. Halpin and D. P. Tashkin, “Defining disease modification in chronic obstructive pulmonary disease,” Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 3, pp. 211–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Laguna, B. D. Wagner, B. Starcher et al., “Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation,” Pediatric Pulmonology, vol. 47, no. 9, pp. 856–863, 2012. View at Publisher · View at Google Scholar
  11. I. D. Freire, F. A. De Abreu E Silva, and M. Â. De Araújo, “Comparison among pulmonary function test results, the Shwachman-Kulczycki score and the Brasfield score in patients with cystic fibrosis,” Jornal Brasileiro de Pneumologia, vol. 34, no. 5, pp. 280–287, 2008. View at Google Scholar · View at Scopus
  12. C. D. A. D. Alves, R. A. Aguiar, A. C. S. Alves, and M. A. Santana, “Diabetes mellitus in patients with cystic fibrosis,” Jornal Brasileiro de Pneumologia, vol. 33, no. 2, pp. 213–221, 2007. View at Google Scholar · View at Scopus
  13. H. R. Rabin, S. M. Butler, M. E. B. Wohl et al., “Pulmonary exacerbations in cystic fibrosis,” Pediatric Pulmonology, vol. 37, no. 5, pp. 400–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kapur, I. B. Masters, P. S. Morris, J. Galligan, and R. Ware, “Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis,” Pediatric Pulmonology, vol. 47, pp. 68–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Eichler, M. Nilsson, R. Rath, I. Enander, P. Venge, and D. Y. Koller, “Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis,” European Respiratory Journal, vol. 14, no. 5, pp. 1145–1149, 1999. View at Google Scholar · View at Scopus
  16. A. C. Tanrikulu, A. Abakay, O. Evliyaoglu, and Y. Palanci, “Coenzyme Q10, Copper, Zinc, and Lipid Peroxidation levels in serum of patients with chronic obstructive pulmonary disease,” Biological Trace Element Research, pp. 659–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Y. El-Seify, T. A. Kamel, M. I. El-Mogy, and S. H. Ossman, “Serum human neutrophil lipocalin in pediatric chronic lung diseases: a novel marker of ongoing neutrophilic inflammation,” Egyptian Journal of Bronchology, vol. 5, no. 1, 2011. View at Google Scholar
  18. D. B. Sanders, R. C. L. Bittner, M. Rosenfeld, G. J. Redding, and C. H. Goss, “Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis,” Pediatric Pulmonology, vol. 46, no. 4, pp. 393–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Antuni, S. A. Kharitonov, D. Hughes, M. E. Hodson, and P. J. Barnes, “Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis,” Thorax, vol. 55, no. 2, pp. 138–142, 2000. View at Publisher · View at Google Scholar · View at Scopus